Updated Jul 16, 2026
Knowles Jonathan Kenneth Charles has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Based on the SEC filing context, Jonathan Kenneth Charles Knowles is listed as a Director of Caris Life Sciences, Inc. as of the most recent filing dated 2026-06-02. No additional biographical details are provided in the SEC context provided. The name appears in the common corporate-filing order as Knowles Jonathan Kenneth Charles, which likely corresponds to the standard Western name form Jonathan Kenneth Charles Knowles.
| Role | Director |
|---|---|
| Notability | 55/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | CAI | Caris Life Sciences, Inc. | A — Grant or award | 1.6K | $15.62 | $25K |
Based on the SEC filing context, Jonathan Kenneth Charles Knowles is listed as a Director of Caris Life Sciences, Inc. as of the most recent filing dated 2026-06-02. No additional biographical details are provided in the SEC context provided. The name appears in the common corporate-filing order as Knowles Jonathan Kenneth Charles, which likely corresponds to the standard Weste…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Knowles Jonathan Kenneth Charles profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.